https://www.selleckchem.com/pr....oducts/afuresertib-g
769±0.05) significantly improved the diagnostic rate for early HCC, indicating that G-test and AFP complemented each other. G-test was better than AFP for screening HCC in patients with chronic hepatitis B and cirrhosis. The combination of the two further improved the diagnostic rate of hepatitis B-related liver cancer. The G-test improves the screening rate of early HCC in patients with cirrhosis. Therefore, these markers are of great clinical significance and can improve the sensitivity of HCC detection and reduce misse
Like
Comment
Share
